Physician

Robert M Langdon, M.D.

According to 2025 Medicare claims, Robert Langdon, M.D. (NPI: 1689654618) practices medical oncology in the Omaha, NE-IA market, with the plurality of this provider's patient population coming from Douglas, NE. This provider's primary affiliated billing organization is ONCOLOGY HEMATOLOGY WEST, PC (NPI: 1932178530; TIN: 470754790) and primary practice location at 68114-4108. Langdon is affiliated with the NPG Health Collaborative LLC (ACO ID: A3287) and CoreHealth Alliance LLC (ACO ID: A5645), participating under the MSSP model.

Langdon's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 973 traditional Medicare patients, billed 157,577 HCPCS/CPT codes, and received $2,659,986 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 1,573 prescription claims across 196 beneficiaries totaling $3,559,424 in drug costs, led by Ibrance (Palbociclib). DME data shows 43 claims. Open Payments data shows 20 records totaling $106,831. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $2,065,086 and ending at $2,659,986. Concurrently, Part D prescription costs have moved from a lower plateau to a higher plateau, from $668,120 to $3,559,424. In contrast, DME billing represents a smaller volume and fell sharply in recent years, from $6,854 to $0.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,220	159,307	$2,065,086
2016	1,298	165,599	$2,421,410
2017	1,197	213,902	$2,926,219
2018	1,210	225,445	$3,036,758
2019	1,189	246,442	$3,893,470
2020	1,235	232,318	$4,032,503
2021	1,115	151,717	$2,315,624
2022	1,075	185,148	$3,022,769
2023	1,073	149,291	$2,738,616
2024	973	157,577	$2,659,986

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	210	1,043	$668,120
2016	216	952	$828,292
2017	217	970	$996,872
2018	281	1,501	$1,433,732
2019	289	1,556	$1,689,478
2020	251	1,481	$3,075,652
2021	238	1,415	$2,306,917
2022	231	1,476	$2,564,950
2023	215	1,450	$2,813,804
2024	196	1,573	$3,559,424

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	12	99	$52,545
2016	11	55	$12,926
2017	14	67	$14,042
2018	N/R	51	$5,299
2019	13	75	$6,036
2020	11	44	$3,186
2021	11	155	$8,696
2022	N/R	26	$890
2023	N/R	N/R	N/R
2024	N/R	43	$963

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	694	1,589	$86
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	112	191	$61
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	265	308	$12
80053	Blood test, comprehensive group of blood chemicals	438	1,208	$10
85025	Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count	442	1,466	$8

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Ibrance	Palbociclib	64	1,792	$989,614
Imbruvica	Ibrutinib	56	1,628	$577,567
Revlimid	Lenalidomide	23	644	$409,657
Tagrisso	Osimertinib Mesylate	18	540	$305,108
Lenalidomide	Lenalidomide	22	616	$300,109

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
J8700	Temozolomide, oral, 5 mg	N	N/R	16	$568
Q0511	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for the first prescription in a 30-day period	N	N/R	12	$207
Q0512	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for a subsequent prescription in a 30-day period	N	N/R	15	$188

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	9	$184	ABBVIE INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	11	$106,647	E.R. Squibb & Sons, L.L.C.
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Robert M. Langdon, M.D.?

Tedicare shows public-source Medicare data for Robert M. Langdon, M.D. (NPI 1689654618), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Robert M. Langdon, M.D. have ACO affiliation data?

Robert M. Langdon, M.D. is shown with ACO affiliation data for NPG Health Collaborative LLC (MSSP, ACO ID A3287) and CoreHealth Alliance LLC (MSSP, ACO ID A5645).

What billing organization is linked to Robert M. Langdon, M.D.?

Robert M. Langdon, M.D. is linked to ONCOLOGY HEMATOLOGY WEST, PC (billing NPI 1932178530) in the available physician profile data.

Does Robert M. Langdon, M.D. have Open Payments data?

Robert M. Langdon, M.D. has 20 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.